Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
OBJECTIVES:
I. Compare tolerance to and therapeutic impact of copolymer 1, a mixture of synthetic
polypeptides, with placebo in patients with relapsing-remitting multiple sclerosis.
Phase:
Phase 3
Details
Lead Sponsor:
National Center for Research Resources (NCRR)
Collaborators:
University of Maryland University of Maryland, College Park